ADVERTISEMENT
Former FDA Commissioner Frank Young Dies
Former FDA Commissioner Frank Young Dies
The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.
Former FDA Commissioner Frank Young Dies
Former FDA Commissioner Frank Young Dies

The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.

The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.

biotech

Trial of Gene Therapy for Duchenne Muscular Dystrophy Put on Hold
Catherine Offord | Nov 12, 2019 | 2 min read
The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.
smartphone controlled device implanted in mouse brain
Image of the Day: Smartphone-Controlled Brains
Nicoletta Lanese | Aug 7, 2019 | 1 min read
A device implanted into mice can modulate brain circuit activity over long periods of time.
LOCKR de novo protein designed to function as a molecular switch
Designer Protein Acts as a Switch for Cellular Circuitry
Nicoletta Lanese | Jul 25, 2019 | 2 min read
Unlike biotech tools adapted from nature, the invention was entirely conceived by humans and represents one of the few proteins made from scratch in the lab.
MIT Researcher Allegedly Copied Other Groups’ Drug Designs
Catherine Offord | May 29, 2019 | 2 min read
Executives at a biotech that develops new antibodies argue that Ram Sasisekharan didn’t come up with the structures for at least two experimental therapies that his group has described.
computing a cure
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019 | 8 min read
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
AI App Identifies Rare Genetic Disorders from Photos of Patients’ Faces
Catherine Offord | Jan 8, 2019 | 2 min read
Deep-learning algorithms could help doctors narrow in on the causes of certain medical conditions, say researchers.
two men carry large tusks over a beach
Genesis 2.0 Is a Beautifully Shot, Cautionary Tale About Biotechnology
Shawna Williams | Jan 2, 2019 | 2 min read
The documentary weaves together a hunt for mammoth tusks in the Arctic with scenes from the front lines of synthetic biology.
Zimbabwe’s Medical Marijuana Future Uncertain
Tonderayi Mukeredzi | Sep 12, 2018 | 2 min read
The country is the second in Africa to permit cannabis cultivation, but months after approval there’s been little uptake by farmers and no scientific proposals.
Synthetic Bacteria Help Treat Phenylketonuria in Mice
Diana Kwon | Aug 17, 2018 | 2 min read
The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.
CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018 | 2 min read
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Jim Daley | Jan 31, 2018 | 2 min read
Biotech stocks fell in response to the news. 
Equivocal Findings of Alzheimer’s Trial Using Young Blood
Catherine Offord | Nov 5, 2017 | 2 min read
A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017 | 10 min read
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Was a Drop in CRISPR Firms’ Stock Warranted?
Claire Asher | Jun 7, 2017 | 4 min read
A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.
CAR T-Cell Trials Boast Promising Results
Diana Kwon | Jun 5, 2017 | 2 min read
The results of two small clinical trials show that the immunotherapy is effective for multiple myeloma patients, at least in the near term.
Learning from Iceland’s Model for Genetic Research
Catherine Offord | Jun 1, 2017 | 8 min read
The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.
Former Head of Genzyme Dies
Diana Kwon | May 15, 2017 | 2 min read
Henri Termeer helped usher the biotech company into an industry behemoth.
Life Science Leaders Meet at White House
Kerry Grens | May 8, 2017 | 1 min read
Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.
Opinion: Preparing for Potential Disasters
Larissa Paschyn | Jan 25, 2017 | 3 min read
How to increase the resiliency of biotechnology organizations in the face of emergency risks
ADVERTISEMENT